Activity value 72colombia Buyer,Last transaction date:
2026-01-23
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for improvit medical s.a.s. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 1.95 and a transaction weight of 1.95.
YearTransactionsQuantityWeight
20253128.0828.08
202621.951.95
Bill of lading data
<
1/15
>
Trade date
2026/01/23
B/L No.
91003048736393
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
1.56kg
Amount
593.1
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP6376 PEDIDO 2378195540 (1 PARCIAL) DECLARACION 1 DE 2 FACTURA:HPIPL25-260943, FECHA:06-12-2025, REGIST
Expand
Trade date
2026/01/23
B/L No.
91003048736481
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.39kg
Amount
148.28
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP6376 PEDIDO 2378195540 (1 PARCIAL) DECLARACION 2 DE 2 FACTURA:HPIPL25-260943, FECHA:06-12-2025, REGIST
Expand
Trade date
2025/12/10
B/L No.
91003048134580
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.05kg
Amount
70.15
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP6046 PEDIDO 1265290331 (4 PARCIAL) DECLARACION 1 DE 1 //FACTURA:HPIPL/25-26/0314, FECHA:25-06-2025, REGIST
Expand
Product description
DO FESTEXTIMP6005 PEDIDO GUIA 724-79700084 DECLARACION 1 DE 1 //FACTURA:SO25-07503, FECHA:05-11-2025, REGISTRO DE IMPOR
Expand
Trade date
2025/11/29
B/L No.
91003047973322
Suppliers
biozenta lifescience pvt ltd.
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
5.41kg
Amount
5472
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5971 PEDIDO 074-72532891 - 2 PARCIAL DECLARACION 1 DE 1; //FACTURA:EXP/25-26/, FECHA:01-11-2025, REGISTRO DE IMPORTACION NO. 50222186 DEL 25/11/2025; VINVIMA-25-0164414; AUTORIZACION NO. 2025001950 DEL 14/11/2025 , PRODUCTO: MEDICAMENTO, NOMBRE COMERCIAL: DAUNORUBICINA LIPOSOMAL 50 MG/25 ML (2 MG/ML) SOLUCION INYECTABLE (PEG DAUNDNO), PRINCIPIO ACTIVO: DAUNORUBICINA LIPOSOMAL, CONCENTRACION: 50 MG, INDICACIONES TERAPEUTICAS: ESTA INDICADO COMO ALTERNATIVO A LA DAUNORUBICINA CONVENCIONAL Y COADYUVANTE PARA EL TRATAMIENTO DE, SARCOMA DE KAPOSI RELACIONADO CON EL SIDA, FORMA FARMACEUTICA: SOLUCION INYECTABLE, TIPO DE EMPAQUE: CAJAS X 1 VIAL DE 25 ML/50 MG, USO: HUMANO, MARCA: PEG DAUNDNO, (MERCANCIA NUEVA), MEDICAMENTO VITAL NO DISPONIBLE, NUMERO DE RADICADO INVIMA: 20251332034, FECHA RADICACION:11/11/2025, AUTORIZACION: 2025001950, DEL 14/11/2025, CODIGO IUM: 1D1000031004100, PRINCIPIO ACTIVO: DAUNORUBICINA LIPOSOMAL,CONCENTRACION: 50 MG, CANTIDAD PARA IMPORTAR: VEINTICUATRO (24) CAJAS X 1 VIALDE
Expand
Trade date
2025/11/20
B/L No.
91003047808289
Suppliers
biozenta lifescience pvt ltd.
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.89kg
Amount
912
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5907 PEDIDO 074-72532891 - 1 PARCIAL DECLARACION 1 DE 1; //FACTURA:EXP/25-26/, FECHA:01-11-2025, REGISTRO DE IMPORTACION NO. 50215426 17/11/2025; VINVIMA-25-0159184; AUTORIZACION NO. 2023000660 DEL 29/06/2023 , PRODUCTO: MEDICAMENTO, NOMBRE COMERCIAL: DAUNORUBICINA LIPOSOMAL 50 MG/25 ML (2 MG/ML) SOLUCION INYECTABLE (PEG DAUNDNO),PRINCIPIO ACTIVO: DAUNORUBICINA LIPOSOMAL, CONCENTRACION: 50 MG, INDICACIONES TERAPEUTICAS: ESTA INDICADO COMO ALTERNATIVO A LA DAUNORUBICINA CONVENCIONAL Y COADYUVANTE PARA EL TRATAMIENTO DE, SARCOMA DE KAPOSI RELACIONADO CON EL SIDA, FORMA FARMACEUTICA: SOLUCION INYECTABLE, TIPO DE EMPAQUE: CAJAS X 1 VIAL DE 25 ML/50 MG, USO: HUMANO, MARCA: PEG DAUNDNO, (MERCANCIA NUEVA), MEDICAMENTO VITAL NO DISPONIBLE, NUMERO DERADICADO INVIMA: 20231148242, FECHA RADICACION:05/06/2023, AUTORIZACION: 2023000660, DEL 29/06/2023, CODIGO IUM: 1D1000031004100, CANTIDAD PARA IMPORTAR: CUATRO (4) CAJAS X 1 VIAL DE 25 ML, NOMBRE COMPLETO DEL PACIENTE: ALVAREZ GONZALEZ ALEJANDRO , TIPO DE DO
Expand
Trade date
2025/10/22
B/L No.
91003047304393
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.22kg
Amount
222.81
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5653 PEDIDO BG250298 DECLARACION 1 DE 3 //FACTURA:HPIPL/25-26/0314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/10/22
B/L No.
91003047304014
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.39kg
Amount
396.1
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5653 PEDIDO BG250298 DECLARACION 2 DE 3 //FACTURA:HPIPL/25-26/0314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/10/22
B/L No.
91003047304521
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.29kg
Amount
297.07
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5653 PEDIDO BG250298 DECLARACION 3 DE 3 //FACTURA:HPIPL/25-26/0314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/09/18
B/L No.
91003046780731
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.39kg
Amount
396.1
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5429 PEDIDO BG250233 DECLARACION 3 DE 4 FACTURA:HPIPL25-260314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/09/18
B/L No.
91003046780682
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.58kg
Amount
594.15
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5429 PEDIDO BG250233 DECLARACION 2 DE 4 FACTURA:HPIPL25-260314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/09/18
B/L No.
91003046780858
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.3kg
Amount
297.07
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5429 PEDIDO BG250233 DECLARACION 4 DE 4 FACTURA:HPIPL25-260314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/09/18
B/L No.
91003046780066
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.15kg
Amount
148.54
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO FESTEXTIMP5429 PEDIDO BG250233 DECLARACION 1 DE 4 FACTURA:HPIPL25-260314, FECHA:25-06-2025, REGISTRO DE IMPORTAC
Expand
Trade date
2025/07/25
B/L No.
91003045913373
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.58kg
Amount
594.16
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO TCI113311 PEDIDO PEDIDO BG250206 DECLARACION 1 DE 4 FACTURA(S):HPIPL/25-26/0314 // FACTURA:HPIPL/25-26/0314, FECHA:2
Expand
Trade date
2025/07/25
B/L No.
91003045913674
Suppliers
healing pharma
Buyers
improvit medical s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
0.29kg
Amount
297.07
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO TCI113311 PEDIDO PEDIDO BG250206 DECLARACION 2 DE 4 FACTURA(S):HPIPL/25-26/0314 // FACTURA:HPIPL/25-26/0314, FECHA:2
Expand
+View All
Partners
Total 5
RankCompanyTransactionsPerDetail
1healing pharma
indiasupplier,they trade on 2026-01-23
9163.19%
>
3g m global
indiasupplier,they trade on 2022-11-08
53.47%
>
4gm global
united statesbuyer,they trade on 2022-11-08
53.47%
>
5beldimed
turkeysupplier,they trade on 2025-12-03
10.69%
>
Products
Total 6
ProductsTransactionsPerDetail
equipped with fixed dose drug 7398.65%>
liposome 11.35%>
daunorubicin 11.35%>
injection 11.35%>
citrate 11.35%>
+View All
Hscode rank
Total 5
HSCode NameTransactionsPerDetail
HS 30049029005472.97%>
HS 30049024001925.68%>
HS 3004904911.35%>
Trading Area
Total 4
AreaTransactionsPerDetail
india12586.81%>
costa rica128.33%>
china64.17%>
belgium10.69%>
Port statistics
Total 1
Port NameTransactionsPerDetail
bogota4531.25%>
improvit medical s.a.s. is colombia Buyer,
and primarily engages in the import and export business of products such as equipped with fixed dose drug,liposome,daunorubicin.
According to the 52wmb.com global trade database, as of 2026-01-23, the company has completed 144 international trades,
with its main trading regions covering india,costa rica,china etc.
The core products include HS3004902900,HS3004902400,HS30049049 etc,
often transported via bogota etc,
and its main trading partners are healing pharma,biozenta lifescience pvt ltd.,g m global.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on improvit medical s.a.s. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.